InsiderTrades

Form 4 for TMDX TransMedics Group, Inc.

Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0000950170-24-069424 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2024-06-05 2024-06-03 TMDX Gordon Stephen CFO S - Sale+OE $135.93 -2,060 21.3K -9% -$280.0K
DT 2024-06-05 2024-06-03 TMDX Gordon Stephen CFO M - OptEx $38.46 +2,060 23.4K +10% +$79.2K
DT 2024-06-05 2024-06-03 TMDX Gordon Stephen CFO M - OptEx $0.00 -2,060 15.4K -12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-03 S D 2,060 $135.93 21,299 D — —
2 Common Common Stock 2024-06-03 M A 2,060 $38.46 23,359 D — —
3 Derivative Stock Option (Right to Buy) 2024-06-03 M D 2,060 $0.00 15,417 D $38.46 · — to 2031-02-24 2,060 Common Stock (F2) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.